Cargando…

Sars-Cov-2 Infection Promotes Endothelial Dysfunction and Thrombosis in a Mouse Model of COVID-19

Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Most infected individuals are asymptomatic or show only mild symptoms, but 20% of infected individuals become severely ill resulting in a 2-5% mortality rate for severe infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aiolfi, Roberto, Ahmed, Jeanine, de la Torre, Juan Carlos, Griffin, John H., Mosnier, Laurent O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2021
Materias:	301.Vasculature, Endothelial Cells and Platelets: Basic and Translational
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701651/ http://dx.doi.org/10.1182/blood-2021-148713

Ejemplares similares

The Role of PF4 Antibodies in Pediatric Sars-Cov-2 Infections
por: Chiem, Meady, et al.
Publicado: (2021)

Circulating Levels of Ang/Tie2 and VEGF-a Pathway Mediators Are Associated with Clinical Severity, Endothelial Barrier Disruption and Coagulation Activation in COVID-19
por: de Moraes, Carla Roberta Peachazepi, et al.
Publicado: (2021)

Sars-Cov-2 Induced Endotheliopathy and the Impact on Clinical Outcomes in Critically Ill Pediatric Patients
por: Agarwal, Shreya, et al.
Publicado: (2021)

Inhibition of Sars-Cov-2 Viral Replication and In Vivo Thrombus Formation By a Novel Plant Flavonoid
por: Yang, Moua, et al.
Publicado: (2021)

The Deglycosylated Form of 1E12, a Monoclonal Anti-PF4 IgG, Strongly Inhibits Antibody-Triggered Cellular Activation in Vaccine-Induced Thrombotic Thrombocytopenia, and Is a Potential New Treatment for Vιττ
por: Vayne, Caroline, et al.
Publicado: (2021)

Hospital Outcomes Among Covid-19 Hospitalizations With Myocarditis: Results From California State Inpatient Database
por: Carcamo, Francisco Javier Jimenez, et al.
Publicado: (2023)

Evidence of Microangiopathy in Children with Sars-Cov-2 Regardless of Clinical Presentation
por: Diorio, Caroline, et al.
Publicado: (2020)

Ca(v)3.2 T‐type calcium channel regulates mouse platelet activation and arterial thrombosis
por: Tamang, Hem Kumar, et al.
Publicado: (2022)

The Role of Fibrinolytic Factors, a Subset of Angiocrine Factors in Cytokine Storm-Associated Diseases
por: Hattori, Koichi, et al.
Publicado: (2020)

Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty
por: Moreno-Castaño, Ana Belen, et al.
Publicado: (2020)

The chaperone protein HSP47: a platelet collagen binding protein that contributes to thrombosis and hemostasis
por: Sasikumar, P., et al.
Publicado: (2018)

Sex-Specific Differences in the Pathogenesis, Endothelial Dysfunction, and Hypercoagulability of Sars-Cov-2 Infection in K18-hACE2 Mice
por: Aiolfi, Roberto, et al.
Publicado: (2022)

A humanized monoclonal antibody that inhibits platelet‐surface ERp72 reveals a role for ERp72 in thrombosis
por: Holbrook, L.‐M., et al.
Publicado: (2018)

Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti‐β2‐GPI antibodies
por: Capozzi, Antonella, et al.
Publicado: (2021)

Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro
por: Ji, Shuting, et al.
Publicado: (2019)

Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy
por: Skoro-Sajer, Nika, et al.
Publicado: (2014)

Assessment of proximal pulmonary arterial stiffness using magnetic resonance imaging: effects of technique, age and exercise
por: Weir-McCall, Jonathan R, et al.
Publicado: (2016)

High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice
por: Schlosser, Kenny, et al.
Publicado: (2018)

Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study
por: Yorke, Janelle, et al.
Publicado: (2018)

Veterans Specific Activity Questionnaire (VSAQ): a new and efficient method of assessing exercise capacity in patients with pulmonary arteriovenous malformations
por: Gawecki, Filip, et al.
Publicado: (2019)

Fever is associated with higher morbidity and clot burden in patients with acute pulmonary embolism
por: Saad, Muhammad, et al.
Publicado: (2018)

Combining creative writing and narrative analysis to deliver new insights into the impact of pulmonary hypertension
por: Goddard, Julia C, et al.
Publicado: (2017)

Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
por: Harbaum, Lars, et al.
Publicado: (2019)

Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
por: Dotan, Yaniv, et al.
Publicado: (2020)

Safety and efficacy of catheter directed thrombolysis (CDT) in elderly with pulmonary embolism (PE)
por: Harrison, Eneida, et al.
Publicado: (2021)

Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance
por: Fartoukh, Muriel, et al.
Publicado: (2021)

Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
por: Heukels, Peter, et al.
Publicado: (2021)

Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study
por: Takita, Yuka, et al.
Publicado: (2021)

Incidence and outcomes of pulmonary hypertension in the Ireland
por: Cullivan, Sarah, et al.
Publicado: (2022)

Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension
por: Pi, Hongyang, et al.
Publicado: (2022)

Signs and symptoms of acute pulmonary embolism and their predictive value for all-cause hospital death in respect of severity of the disease, age, sex and body mass index: retrospective analysis of the Regional PE Registry (REPER)
por: Ružičić, Dušan Predrag, et al.
Publicado: (2023)

Optimal length of oral anticoagulant treatment for maximum benefit within 5 years after discontinuation of oral anticoagulants in patients with acute pulmonary embolism who require secondary thromboprophylaxis
por: Zhao, Yunfeng, et al.
Publicado: (2023)

Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study
por: Samaranayake, Chinthaka Bhagya, et al.
Publicado: (2023)

Localized endothelial‐based control of platelet aggregation and coagulation under flow: A proof‐of‐principle vessel‐on‐a‐chip study
por: Brouns, Sanne L.N., et al.
Publicado: (2020)

A gain‐of‐function filamin A mutation in mouse platelets induces thrombus instability
por: Adam, Frédéric, et al.
Publicado: (2022)

CLEC‐2‐dependent activation of mouse platelets is weakly inhibited by cAMP but not by cGMP
por: Borgognone, A., et al.
Publicado: (2014)

Hypothermia‐induced activation of the splenic platelet pool as a risk factor for thrombotic disease in a mouse model
por: Horioka, Kie, et al.
Publicado: (2019)

Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells
por: Moraes, L A, et al.
Publicado: (2010)

Cataract surgery in patients with Fuchs' endothelial corneal dystrophy
por: Kaup, Soujanya, et al.
Publicado: (2019)

The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis
por: Senis, Yotis A., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_deirhl4a02hnob266pqthtqknb